Publications by authors named "A Whitelaw"

Claim this Profile
P
Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).
Adrie Bekker, Navarat Panjasawatwong, Louise F Hill, Wolfgang Stohr, A Sarah Walker, Andrew Whitelaw

Antimicrob Agents Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic lavage after intraventricular haemorrhage in neonates in the UK (ENLIVEN-UK): study protocol for a national randomised-controlled trial.
Saniya Mediratta, Aswin Chari, Cheryl Battersby, Patrick Bauserman, Emilia Caverly, Andrew Whitelaw

Trials· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of carbapenem-resistant Enterobacterales colonisation in hospitalised neonates.
Michele E Haumann, Adrie Bekker, Chandre Geldenhuys, Natasha O'Connell, Andrew Whitelaw

S Afr J Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of transferable daptomycin resistance in Gram-positive bacteria.
Tessa Marciniak, Lukas Kirchner, Silver A Wolf, Birgit Walther, Thorsten Bischler, Andrew Whitelaw

NPJ Antimicrob Resist· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Bloodstream Infection Surveillance Programme at a Resource-Limited South African Neonatal Unit.
Frances Ashton, Adrie Bekker, Magdalena Aucamp, Kessendri Reddy, Andrew Whitelaw

Antibiotics (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis